Description: Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.
Home Page: www.aclarion.com
ACON Technical Analysis
951 Mariners Island Boulevard
San Mateo,
CA
94404
United States
Phone:
650-241-1741
Officers
| Name | Title |
|---|---|
| Dr. Jeffrey John Thramann M.D. | Exec. Chairman |
| Mr. Brent Ness | CEO, Pres & Director |
| Mr. John Lorbiecki | Chief Financial Officer |
| Mr. Ryan Bond | Chief Strategy Officer |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.9069 |
| Price-to-Sales TTM: | 91.8187 |
| IPO Date: | 2022-04-22 |
| Fiscal Year End: | December |
| Full Time Employees: | 3 |